Dr. Davis said he felt the B. stearothermophilis was a 
particularly valuable organism for research because it is 
extremely heat-resistant and, therefore, would be of use in 
obtaining a variety of enzymes. He questioned whether the 
spelling of the organism was correct in the request and said he 
believed the ending of the word should be "us" versus "is" as it 
currently appears. He asked the staff to ensure the proper 
spelling . 
Dr. Gottesman said her only question was whether this organism 
was explicitly discussed when the original Appendix C-V list was 
made. Dr. Clewell responded that he felt it was merely an 
omission or that some information may have been missing at the 
time which would have allowed it to be included in the original 
list. Dr. Cohen added that he supported the proposal. 
Mr. Mitchell asked if there was anyone present who had any 
reservations about the proposal to which there was no response. 
Further, Dr. Gartland stated there were no comments in any 
correspondence that had been received by the Office of 
Recombinant DNA Activities (ORDA). 
Dr. Davis made a motion that the RAC accept the proposal to add 
B. stearothermophilis to Appendix C-V of the NIH Guidelines. Dr. 
Clewell seconded the motion. The motion, having been duly made 
and seconded, was put to a vote by Mr. Mitchell and was carried 
by a vote of 18 in favor, none opposed, and no abstentions. 
V. PROPOSAL TO AMEND SECTION I-C OF THE NIH GUIDELINES (tabs 1290/1, 
1293, 1294, 1301, 1302, 1306, and 1309). 
Mr. Mitchell called on Dr. Johnson as primary reviewer to present 
the proposal. Dr. Johnson said the proposal had been submitted 
by Mr. Edward Lee Rogers, attorney for the Foundation on Economic 
Trends, and Mr. Jeremy Rif kin. Foundation on Economic Trends, to 
add several statements after the first sentence of the third 
paragraph of Section I-C which, in Dr. Johnson's opinion, was an 
attempt to define the word "project" in very legalistic terms 
resembling statutory language which in his opinion was difficult 
to understand. Furthermore, Dr. Johnson said he felt that since 
both the NIH Guidelines as well as the RAC were advisory, not 
regulatory, in nature that the language did not add anything 
useful to the NIH Guidelines. Also, Dr. Johnson noted that four 
letters had been received by ORDA, and all four expressed the 
opinion that RAC should reject the proposal. Among the reasons 
for the need of such an amendment cited by Messrs. Rif kin and 
Rogers was the suggestion that the NIH had supported the testing 
of a Pseudorabies vaccine in Argentina. NIH had concluded that 
[ 48 ] 
Recombinant DNA Research, Volume 13 
